{"filing":{"accession_number":"0001477932-26-003844","cik":"0001289047","ticker":null,"company_name":"AI Technology Group Inc.","form":"8-K","filing_date":"2026-06-12","report_date":null,"primary_document":"aipg_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1289047/000147793226003844/aipg_8k.htm"},"events":[{"id":10353,"run_id":9080,"accession_number":"0001477932-26-003844","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"This Item 1.01 discloses a material amendment to an Agreement and Plan of Merger between AI Technology Group Inc., AVM Biotechnology Inc., and Biomed 360 Solutions Corp. The June 4, 2026 amendment modifies critical merger terms including investment obligations (tranches totaling over $50 million), conversion rates for convertible loans, and extends the Closing Date from July 26, 2026 to December 31, 2026. These are substantive changes to a material acquisition transaction that would significantly affect investor assessment of the merger's timing, financing structure, and likelihood of completion.","company_name":"AI Technology Group Inc.","ticker":null,"filing_date":"2026-06-12","form":"8-K","submitted_at":null,"items":[{"id":6646,"accession_number":"0001477932-26-003844","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"This Item 1.01 discloses a material amendment to an Agreement and Plan of Merger between AI Technology Group Inc., AVM Biotechnology Inc., and Biomed 360 Solutions Corp. The June 4, 2026 amendment modifies critical merger terms including investment obligations (tranches totaling over $50 million), conversion rates for convertible loans, and extends the Closing Date from July 26, 2026 to December 31, 2026. These are substantive changes to a material acquisition transaction that would significantly affect investor assessment of the merger's timing, financing structure, and likelihood of completion.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:04:42.023156+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6646,"accession_number":"0001477932-26-003844","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"This Item 1.01 discloses a material amendment to an Agreement and Plan of Merger between AI Technology Group Inc., AVM Biotechnology Inc., and Biomed 360 Solutions Corp. The June 4, 2026 amendment modifies critical merger terms including investment obligations (tranches totaling over $50 million), conversion rates for convertible loans, and extends the Closing Date from July 26, 2026 to December 31, 2026. These are substantive changes to a material acquisition transaction that would significantly affect investor assessment of the merger's timing, financing structure, and likelihood of completion.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:04:42.023156+00:00","company_name":"AI Technology Group Inc.","ticker":null,"filing_date":"2026-06-12"}]}